[µ¿Á¤] ±èÁö¼· ±³¼ö, ¸»ÃʽŰæ¼ö¼úÇÐȸ ¿ì¼öÇмú»ó
±èÁö¼· À̴뼿ﺴ¿ø Á¤Çü¿Ü°ú ±³¼ö°¡ ÃÖ±Ù ´ë±¸ Wº´¿ø¿¡¼ ¿¸° 2025 ´ëÇѸ»ÃʽŰæ¼ö¼úÇÐȸ(KSSPN) Ãß°èÇмú´ëȸ¿¡¼ ±âÃʺι® ¿ì¼öÇмú»óÀ» ¼ö»óÇß´Ù. Çмú´ëȸ¿¡¼ ±èÁö¼· ±³¼ö´Â ÀÌÈÀÇ´ë »ýÈÇб³½Ç Á¤¼ºÃ¶¡¤¹Ú¼¼¿µ ±³¼ö¿Í °øµ¿À¸·Î ¼öÇàÇÑ ¡®Áß°£¿± Áٱ⼼Æ÷ À¯·¡ ½´¹Ý¼¼Æ÷ À¯»ç¼¼Æ÷ÀÇ Àû¿ëÀ» ÅëÇÑ ¸»ÃÊ½Å°æ ¼Õ»ó ÈÄ ½Å°æ±Ù Á¢ÇպΠº¸Á¸ ¹× ±â´É ȸº¹ ÁõÁø(Application of Mesenchymal Stem Cell-Derived Schwann Cell-like Cells Spared Neuromuscular Junctions and Enhanced Functional Recovery After Peripheral Nerve Injury)¡¯ ¿¬±¸ °á°ú¸¦ ¹ßÇ¥Çß´Ù.